These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 24123667

  • 21. Elevation of endocannabinoids in the brain by synthetic cannabinoid JWH-018: mechanism and effect on learning and memory.
    Li RS, Fukumori R, Takeda T, Song Y, Morimoto S, Kikura-Hanajiri R, Yamaguchi T, Watanabe K, Aritake K, Tanaka Y, Yamada H, Yamamoto T, Ishii Y.
    Sci Rep; 2019 Jul 03; 9(1):9621. PubMed ID: 31270353
    [Abstract] [Full Text] [Related]

  • 22. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
    Mulè F, Amato A, Baldassano S, Serio R.
    Pharmacol Res; 2007 Aug 03; 56(2):132-9. PubMed ID: 17574859
    [Abstract] [Full Text] [Related]

  • 23. Multiple cannabinoid signaling cascades powerfully suppress recurrent excitation in the hippocampus.
    Jensen KR, Berthoux C, Nasrallah K, Castillo PE.
    Proc Natl Acad Sci U S A; 2021 Jan 26; 118(4):. PubMed ID: 33468648
    [Abstract] [Full Text] [Related]

  • 24. Ethanol exposure induces neonatal neurodegeneration by enhancing CB1R Exon1 histone H4K8 acetylation and up-regulating CB1R function causing neurobehavioral abnormalities in adult mice.
    Subbanna S, Nagre NN, Umapathy NS, Pace BS, Basavarajappa BS.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(5):. PubMed ID: 25609594
    [Abstract] [Full Text] [Related]

  • 25. Bladder function in a cannabinoid receptor type 1 knockout mouse.
    Füllhase C, Campeau L, Sibaev A, Storr M, Hennenberg M, Gratzke C, Stief C, Hedlund P, Andersson KE.
    BJU Int; 2014 Jan 31; 113(1):144-51. PubMed ID: 24053792
    [Abstract] [Full Text] [Related]

  • 26. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
    Zádor F, Lénárt N, Csibrány B, Sántha M, Molnár M, Tuka B, Samavati R, Klivényi P, Vécsei L, Marton A, Vizler C, Nagy GM, Borsodi A, Benyhe S, Páldy E.
    Neuropharmacology; 2015 Feb 31; 89():298-307. PubMed ID: 25446673
    [Abstract] [Full Text] [Related]

  • 27. Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus.
    Hoffman AF, Macgill AM, Smith D, Oz M, Lupica CR.
    Eur J Neurosci; 2005 Nov 31; 22(9):2387-91. PubMed ID: 16262678
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of lovastatin on learning and memory deficits caused by chronic intermittent hypoxia-hypercapnia: through regulation of NR2B-containing NMDA receptor-ERK pathway.
    Huo XL, Min JJ, Pan CY, Zhao CC, Pan LL, Gui FF, Jin L, Wang XT.
    PLoS One; 2014 Nov 31; 9(4):e94278. PubMed ID: 24718106
    [Abstract] [Full Text] [Related]

  • 29. Natural (∆9-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB1 receptor.
    Malyshevskaya O, Aritake K, Kaushik MK, Uchiyama N, Cherasse Y, Kikura-Hanajiri R, Urade Y.
    Sci Rep; 2017 Sep 05; 7(1):10516. PubMed ID: 28874764
    [Abstract] [Full Text] [Related]

  • 30. Pharmacological activation of CB1 receptor modulates long term potentiation by interfering with protein synthesis.
    Navakkode S, Korte M.
    Neuropharmacology; 2014 Apr 05; 79():525-33. PubMed ID: 24412673
    [Abstract] [Full Text] [Related]

  • 31. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
    Wise LE, Thorpe AJ, Lichtman AH.
    Neuropsychopharmacology; 2009 Aug 05; 34(9):2072-80. PubMed ID: 19322169
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro.
    Lees G, Dougalis A.
    Brain Res; 2004 Jan 30; 997(1):1-14. PubMed ID: 14715144
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Ras inhibitor S-trans, trans-farnesylthiosalicylic acid enhances spatial memory and hippocampal long-term potentiation via up-regulation of NMDA receptor.
    Wang Y, Chen T, Yuan Z, Zhang Y, Zhang B, Zhao L, Chen L.
    Neuropharmacology; 2018 Sep 01; 139():257-267. PubMed ID: 29578035
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.
    Haller J, Varga B, Ledent C, Freund TF.
    Behav Pharmacol; 2004 Jul 01; 15(4):299-304. PubMed ID: 15252281
    [Abstract] [Full Text] [Related]

  • 39. Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice.
    Zhang RS, He Z, Jin WD, Wang R.
    Neurobiol Learn Mem; 2016 Oct 01; 134 Pt B():264-74. PubMed ID: 27481221
    [Abstract] [Full Text] [Related]

  • 40. A single day of 5-azacytidine exposure during development induces neurodegeneration in neonatal mice and neurobehavioral deficits in adult mice.
    Subbanna S, Nagre NN, Shivakumar M, Basavarajappa BS.
    Physiol Behav; 2016 Dec 01; 167():16-27. PubMed ID: 27594097
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.